<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03133624</url>
  </required_header>
  <id_info>
    <org_study_id>2016YFC1300802</org_study_id>
    <nct_id>NCT03133624</nct_id>
  </id_info>
  <brief_title>A Study on a Multidimensional Prediction Model for Rupture Risk of Unruptured Intracranial Aneurysms</brief_title>
  <acronym>CIAP-2</acronym>
  <official_title>This is a Registry Study on a Multidimensional Prediction Model for Rupture Risk of Unruptured Intracranial Aneurysms in China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Neurosurgical Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Science and Technology of the People's Repubic of China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beijing Neurosurgical Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a registry study on a multidimensional prediction model for rupture risk of
      unruptured intracranial aneurysms in China.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An intracranial aneurysm is swelling along a blood vessel. Ruptured aneurysms, the most
      common cause of nontraumatic subarachnoid hemorrhage, can be catastrophic and have high
      mortality and morbidity rates. The key points of prevention and cure of unruptured
      intracranial aneurysms (UIA) are: (1) clarify the natural history of UIA patients and (2)
      clarify the risk factors of aneurysms. Furthermore, understanding how to reduce the rate of
      rupture, and thus reduce patient mortality, has become a key problem to be solved in this
      field. The aim of this study is to establish a multidimensional model for predicting the
      rupture of unruptured aneurysms.

      The investigators will first establish a prospective cohort of patients with UIA from 20
      different grade centers selected randomly in China, and collect baseline information for each
      patient. Multidimensional data will be acquired in follow-up assessments. Based on the
      original prediction system and the central laboratory and international uniform experimental
      technical specification, the risk factors related to the rupture of UIA, including genes,
      biomarkers, high resolution magnetic resonance images (HRMRI), hemodynamics and clinical
      features will be analyzed. These data will then be used to further improve the prediction
      model of UIA rupture risk.

      After refinement of the model, the evidence-based prediction will provide a theoretical basis
      for the treatment of aneurysms with high rupture risk, so as to improve the prevention and
      control of UIA and avoid uninformed treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>The rupture of intracranial aneurysms</measure>
    <time_frame>Up to 12 months or time of aneurysm repair surgery</time_frame>
    <description>The rupture of unruptured intracranial aneurysms.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in morphology of unruptured intracranial aneurysms</measure>
    <time_frame>Up to 12 months or time of aneurysm repair surgery</time_frame>
    <description>Maximum diameter increase ≥ 1mm or appearance of a daughter sac.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Intracranial Aneurysm</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with at least 1 UIA that is untreated and confirmed by imaging (CTA, MRA and DSA),
        regardless of the presence of clinical symptoms.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 1 UIA that is untreated and confirmed by imaging: Computed tomography
             angiography (CTA), magnetic resonance angiography (MRA) and digital subtraction
             angiography (DSA). Regardless of the presence of clinical symptoms

          -  Patient currently has the ability to live independently, and a modified Ranking Score
             less than or equal to 3 points

          -  Older than 14 years of age

          -  Patient or relatives agreed to sign the consent form

        Exclusion Criteria:

          -  Subarachnoid hemorrhage of unknown origin

          -  Presence of other intracranial vascular malformations, such as cerebral arteriovenous
             malformation (AVM) or cerebral arteriovenous fistula (AVF)

          -  Intracranial and other malignant tumors

          -  Fusiform, traumatic, bacterial or dissecting aneurysm

          -  Patients with severe mental illness who are unable to communicate

          -  Patients with other diseases or poor general condition who are expected to survive
             less than 1 year

          -  Patients with intracranial aneurysms who have joined other similar research
             institutions

          -  Patients who refused follow-up

        The definition of modified Ranking Score:

          -  0 Completely silent

          -  1 Despite symptoms, but not visibly disabled, can complete all regular duties and
             activities

          -  2 Mild disabilities, not all activities previously possible, but can deal with
             personal affairs without need of assistance

          -  3 Moderate disability requires some help, but walking does not need assistance;

          -  4 Severe disabilities, unable to walk independently, no others can not meet their
             needs

          -  5 Severely disabled, bedridden, Urine, requiring continuous care and care;

          -  6 Mortality
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xinjian Yang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Neurosurgical Institute and Beijing Tiantan Hospital affiliated to Capital Medical University，China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jian Liu, MD</last_name>
    <phone>+86-010-67098852</phone>
    <email>jianliu_ns@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Junfan Chen, MS</last_name>
    <phone>+86-010-67098852</phone>
    <email>junfan-chen@foxmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>XuanWu Hospital,Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100053</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peng Hu, MD</last_name>
      <phone>+86-13811385341</phone>
      <email>doctor_hupeng@163.com</email>
    </contact>
    <investigator>
      <last_name>Hongqi Zhang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The 1st Affiliated Hospital of Chongqing Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400016</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zongduo Guo, MD</last_name>
      <phone>+86-13594118695</phone>
      <email>stonegzd@163.com</email>
    </contact>
    <investigator>
      <last_name>Xiaochuan Sun, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhongshan Hospital Xiamen University</name>
      <address>
        <city>Xiamen</city>
        <state>Fujian</state>
        <zip>361000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Junlong Kang, MS</last_name>
      <phone>+86-15960256931</phone>
      <email>kjl295@163.com</email>
    </contact>
    <investigator>
      <last_name>Xinhua Tian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southern Medical University, Zhujiang Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510282</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xin Zhang, MD</last_name>
      <phone>+86-15989058895</phone>
      <email>zhangxin19830818@163.com</email>
    </contact>
    <investigator>
      <last_name>Chuanzhi Duan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mingming Zhang, MD</last_name>
      <phone>+86-13907483144</phone>
      <email>zmm-zh@163.com</email>
    </contact>
    <investigator>
      <last_name>Yugang Jiang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Soochow University</name>
      <address>
        <city>Suzhou</city>
        <state>Jiangsu</state>
        <zip>215006</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wanchun You, MD</last_name>
      <phone>+86-18550038323</phone>
      <email>wcyou@suda.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Zhong Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Liao Cheng People's Hospital</name>
      <address>
        <city>Liaocheng</city>
        <state>Shandong</state>
        <zip>252004</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Qingke Cui, MS</last_name>
      <phone>+86-1378718865</phone>
      <email>45587746@qq.com</email>
    </contact>
    <investigator>
      <last_name>Jiyue Wang, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shenghao Ding, MD</last_name>
      <phone>+86-13817282259</phone>
      <email>ding_sheng_hao@126.com</email>
    </contact>
    <investigator>
      <last_name>Jieqing Wan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University Xi'an, China</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <zip>710038</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wei Guo, MD</last_name>
      <phone>+86-18729985168</phone>
      <email>18729985168@163.com</email>
    </contact>
    <investigator>
      <last_name>Yan Qu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West China Hospital of Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhiyong Liu, MD</last_name>
      <phone>+86-13658021726</phone>
      <email>doctor_lzy@163.com</email>
    </contact>
    <investigator>
      <last_name>Min He, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital Of Xinjiang Medical University</name>
      <address>
        <city>Wulumuqi</city>
        <state>Xinjiang</state>
        <zip>830000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kahriman Kadeer, MS</last_name>
      <phone>+86-18599088599</phone>
      <email>KAHriman@vip.qq.com</email>
    </contact>
    <investigator>
      <last_name>Maimaitili Aisha, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beijing Neurosurgical Institute and Beijing Tiantan Hospital affiliated to Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xinjian Yang, MD</last_name>
      <phone>+86-010-67098852</phone>
      <email>yangxinjian@bjttyy.org</email>
    </contact>
    <contact_backup>
      <last_name>Jian Liu, MD</last_name>
      <phone>+86-010-67098852</phone>
      <email>jianliu_ns@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>Xinjian Yang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms--risk of rupture and risks of surgical intervention. N Engl J Med. 1998 Dec 10;339(24):1725-33. Erratum in: N Engl J Med 1999 Mar 4;340(9):744.</citation>
    <PMID>9867550</PMID>
  </results_reference>
  <results_reference>
    <citation>UCAS Japan Investigators, Morita A, Kirino T, Hashi K, Aoki N, Fukuhara S, Hashimoto N, Nakayama T, Sakai M, Teramoto A, Tominari S, Yoshimoto T. The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med. 2012 Jun 28;366(26):2474-82. doi: 10.1056/NEJMoa1113260.</citation>
    <PMID>22738097</PMID>
  </results_reference>
  <results_reference>
    <citation>Thompson BG, Brown RD Jr, Amin-Hanjani S, Broderick JP, Cockroft KM, Connolly ES Jr, Duckwiler GR, Harris CC, Howard VJ, Johnston SC, Meyers PM, Molyneux A, Ogilvy CS, Ringer AJ, Torner J; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention; American Heart Association; American Stroke Association. Guidelines for the Management of Patients With Unruptured Intracranial Aneurysms: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2015 Aug;46(8):2368-400. doi: 10.1161/STR.0000000000000070. Epub 2015 Jun 18.</citation>
    <PMID>26089327</PMID>
  </results_reference>
  <results_reference>
    <citation>Liu J, Xiang J, Zhang Y, Wang Y, Li H, Meng H, Yang X. Morphologic and hemodynamic analysis of paraclinoid aneurysms: ruptured versus unruptured. J Neurointerv Surg. 2014 Nov;6(9):658-63. doi: 10.1136/neurintsurg-2013-010946. Epub 2013 Nov 12.</citation>
    <PMID>24220206</PMID>
  </results_reference>
  <results_reference>
    <citation>Li MH, Chen SW, Li YD, Chen YC, Cheng YS, Hu DJ, Tan HQ, Wu Q, Wang W, Sun ZK, Wei XE, Zhang JY, Qiao RH, Zong WH, Zhang Y, Lou W, Chen ZY, Zhu Y, Peng DR, Ding SX, Xu XF, Hou XH, Jia WP. Prevalence of unruptured cerebral aneurysms in Chinese adults aged 35 to 75 years: a cross-sectional study. Ann Intern Med. 2013 Oct 15;159(8):514-21. doi: 10.7326/0003-4819-159-8-201310150-00004.</citation>
    <PMID>24126645</PMID>
  </results_reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2017</study_first_submitted>
  <study_first_submitted_qc>April 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2017</study_first_posted>
  <last_update_submitted>June 10, 2017</last_update_submitted>
  <last_update_submitted_qc>June 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Neurosurgical Institute</investigator_affiliation>
    <investigator_full_name>Xinjian Yang, MD</investigator_full_name>
    <investigator_title>Vice Chair of Department of Interventional Neuroradiology of Beijing Neurosurgical Institute</investigator_title>
  </responsible_party>
  <keyword>unruptured intracranial aneurysms</keyword>
  <keyword>rupture risk</keyword>
  <keyword>computational fluid dynamic</keyword>
  <keyword>high resolution magnetic resonance images</keyword>
  <keyword>gene</keyword>
  <keyword>multi dimensional prediction model</keyword>
  <keyword>clinical features</keyword>
  <keyword>risk factors</keyword>
  <keyword>registry study</keyword>
  <keyword>china</keyword>
  <keyword>biomarkers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Rupture</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>we can share the original data 5 years after the study.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

